TW202241449A - 含有依匹斯汀(epinastine)或其鹽之塗敷投與用醫藥組合物 - Google Patents
含有依匹斯汀(epinastine)或其鹽之塗敷投與用醫藥組合物 Download PDFInfo
- Publication number
- TW202241449A TW202241449A TW110148529A TW110148529A TW202241449A TW 202241449 A TW202241449 A TW 202241449A TW 110148529 A TW110148529 A TW 110148529A TW 110148529 A TW110148529 A TW 110148529A TW 202241449 A TW202241449 A TW 202241449A
- Authority
- TW
- Taiwan
- Prior art keywords
- pharmaceutical composition
- epinastine
- salt
- composition according
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020215231 | 2020-12-24 | ||
| JP2020-215231 | 2020-12-24 | ||
| JP2021146903 | 2021-09-09 | ||
| JP2021-146903 | 2021-09-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202241449A true TW202241449A (zh) | 2022-11-01 |
Family
ID=82158673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110148529A TW202241449A (zh) | 2020-12-24 | 2021-12-23 | 含有依匹斯汀(epinastine)或其鹽之塗敷投與用醫藥組合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240074973A1 (https=) |
| EP (1) | EP4268827A4 (https=) |
| JP (2) | JP7124248B1 (https=) |
| KR (1) | KR20230124624A (https=) |
| AU (1) | AU2021410145A1 (https=) |
| TW (1) | TW202241449A (https=) |
| WO (1) | WO2022138826A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025205960A1 (ja) * | 2024-03-27 | 2025-10-02 | 参天製薬株式会社 | エピナスチン又はその塩を含有する経皮投与用医薬組成物と抗アレルギー薬との組み合わせ |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536816A (en) * | 1964-09-30 | 1970-10-27 | Atlas Chem Ind | Water-in-oil emulsion |
| US6387383B1 (en) * | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| KR20050092429A (ko) | 2003-01-22 | 2005-09-21 | 니찌방 가부시기가이샤 | 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법 |
| US20040247686A1 (en) * | 2003-04-04 | 2004-12-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases |
| JP5021155B2 (ja) * | 2003-08-01 | 2012-09-05 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物 |
| WO2005089803A2 (en) * | 2004-03-24 | 2005-09-29 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs |
| CN101217948A (zh) | 2005-07-08 | 2008-07-09 | 千寿制药株式会社 | 包含依匹那丁的透皮吸收眼科制剂 |
| CN101036659A (zh) * | 2006-03-13 | 2007-09-19 | 张文静 | 一组盐酸依匹斯汀制剂及其制备方法 |
| EP2056809A1 (en) * | 2006-08-28 | 2009-05-13 | Senju Pharmaceutical Co., Ltd. | Ophthalmic percutaneous absorption type preparation |
| US20080194544A1 (en) * | 2007-02-08 | 2008-08-14 | Ramesh Krishnamoorthy | Aqueous formulations of epinastine for treating allergic rhinitis |
| KR20240023714A (ko) * | 2015-02-02 | 2024-02-22 | 산텐 세이야꾸 가부시키가이샤 | 폴리아프론 및 이의 안검 투여 |
| JP6134853B1 (ja) * | 2016-10-28 | 2017-05-24 | 参天製薬株式会社 | エピナスチン含有点眼液 |
| JP7355539B2 (ja) * | 2018-07-20 | 2023-10-03 | ロート製薬株式会社 | 眼科組成物 |
| JP7458159B2 (ja) * | 2018-09-28 | 2024-03-29 | ロート製薬株式会社 | 眼科組成物 |
-
2021
- 2021-12-23 US US18/269,474 patent/US20240074973A1/en active Pending
- 2021-12-23 WO PCT/JP2021/047886 patent/WO2022138826A1/ja not_active Ceased
- 2021-12-23 EP EP21910965.9A patent/EP4268827A4/en active Pending
- 2021-12-23 TW TW110148529A patent/TW202241449A/zh unknown
- 2021-12-23 JP JP2022531600A patent/JP7124248B1/ja active Active
- 2021-12-23 AU AU2021410145A patent/AU2021410145A1/en active Pending
- 2021-12-23 KR KR1020237024025A patent/KR20230124624A/ko active Pending
-
2022
- 2022-08-10 JP JP2022128183A patent/JP2022160664A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022138826A1 (ja) | 2022-06-30 |
| JP7124248B1 (ja) | 2022-08-23 |
| EP4268827A4 (en) | 2024-12-11 |
| JP2022160664A (ja) | 2022-10-19 |
| US20240074973A1 (en) | 2024-03-07 |
| KR20230124624A (ko) | 2023-08-25 |
| AU2021410145A1 (en) | 2023-07-27 |
| JPWO2022138826A1 (https=) | 2022-06-30 |
| AU2021410145A9 (en) | 2024-07-25 |
| EP4268827A1 (en) | 2023-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2691412C2 (ru) | Способы и композиции для лечения болезни сухого глаза и других глазных заболеваний | |
| US8652491B2 (en) | Transdermal compositions for anticholinergic agents | |
| JP6209777B2 (ja) | 眼の疾病及び疾患のための組成物及び治療 | |
| JP5722802B2 (ja) | プロスタグランジンを含有するアニオン性水中油型エマルジョンおよびその使用 | |
| KR20230128392A (ko) | 지방 조직의 저감 | |
| US20140037713A1 (en) | Transdermal compositions for anti-cholinergic agents | |
| JP2011513501A (ja) | 局所使用のためのビタミンｋ類似体製剤 | |
| JP7171971B1 (ja) | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 | |
| JP5722803B2 (ja) | プロスタグランジンを含有するカチオン性水中油型エマルジョンおよびその使用 | |
| JP7124248B1 (ja) | エピナスチン又はその塩を含有する塗布投与用医薬組成物 | |
| KR20230097052A (ko) | 개선된 효능을 갖는 백반증 병변의 치료 방법 | |
| KR20250133899A (ko) | 국소 약학적 조성물 및 이의 용도 | |
| CN116669705A (zh) | 含有依匹斯汀或其盐的涂布施予用医药组合物 | |
| KR20240134863A (ko) | 심부 진피 약물 전달을 위한 스피로노락톤의 약학 조성물 | |
| HK40097614A (en) | Pharmaceutical composition for topical administration containing epinastine or salt thereof | |
| HK40091801A (zh) | 含有依匹斯汀或其盐的涂布施予用医药组合物 | |
| JP2024507266A (ja) | ヒドロゲル組成物、ならびに放射線によって引き起こされる皮膚損傷の予防および／または処置におけるその使用 | |
| JP2022001606A (ja) | エピナスチン又はその塩を含有する水性組成物 | |
| JP2025036319A (ja) | クロルフェニラミンマレイン酸塩を含有する医薬組成物 | |
| JP2022515569A (ja) | フェノルドパムの安定な局所用組成物 | |
| WO2025205960A1 (ja) | エピナスチン又はその塩を含有する経皮投与用医薬組成物と抗アレルギー薬との組み合わせ | |
| KR20220124175A (ko) | 건선 및 기타 질병 치료를 위한 국소 시클로스포린 |